Biodesix Inc

BDSX chart

Biodesix Inc news

• Biodesix unveils new molecular residual disease (MRD) testing data at AMP 2026 to enhance cancer monitoring.

  Pluang · Nov 9, 6:14 AM EST

• Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting

  Yahoo Finance · Nov 9, 6:00 AM EST

• Biodesix Plans 2026 Revenue of $101 Million to $103 Million, About 115 Sales Reps

  www.tokenpost.com · Nov 7, 8:22 PM EST

• Biodesix (NASDAQ:BDSX) Share Price Crosses Below 200-Day Moving Average - Should You Sell?

  MarketBeat · Nov 7, 5:16 AM EST

• Biodesix (BDSX) Reports 10% Revenue Growth in Q3 2026 Amid Opera

  GuruFocus · Nov 7, 2:48 AM EST

• Lake Street maintains Biodesix at Buy, lowers price target to $30 from $40

  TradingView · Nov 6, 8:27 PM EST

• Biodesix shares plunge over 50% after revenue g...

  Pluang · Nov 6, 4:33 PM EST

• Biodesix (BDSX) Shares Plunge; Johnson Fistel's Colorado Office Initiates Investigation on Behalf of Investors

  GlobeNewswire · Nov 6, 4:17 PM EST

• $BDSX stock is down 52% today. Here's what we see in our data.

  Quiver Quantitative · Nov 6, 2:18 PM EST

• Biodesix stock slumps on dimmer sales outlook

  BizWest · Nov 6, 2:09 PM EST

• Biodesix (BDSX) Q3 2026 Earnings Call Transcript

  fool.com · Nov 6, 10:31 AM EST

• Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?

  Yahoo Finance · Nov 6, 10:16 AM EST

Biodesix Inc key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-05
• 10-Q10-Q2026-11-05
• 8-K8-K2026-11-05
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-05-20
• 10-Q10-Q2026-05-04
• 8-K8-K2026-05-04
• DEF 14ADEF 14A2026-04-09
• 10-K10-K2026-02-26
• 8-K8-K2026-02-26
• 8-K/A8-K/A2026-01-12

About Biodesix Inc

Ticker

BDSX (Nasdaq)

Industry

Services-Medical Laboratories

Headquarters

Louisville, CO

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1439725

Frequently asked questions